Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000438547

Medchemexpress LLC 19,21-Dinorchol-4-en-20(22)-yn-3-one,17-hydroxy-23,23-dimethyl-11-[4-[methyl(1-methylethyl)amino]phe | 2222344-98-9 | 98.1% | 501.74 | 1 MG
SDP

Catalog No. 5000438547
Encompass_Preferred

ORIC-101 is a highly potent and selective glucocorticoid receptor antagonist, with an EC50 of 5.6 nM. It has anti-cancer activity. Additionally, ORIC-101 is a click chemistry reagent, which means it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

  • Highly potent and selective glucocorticoid receptor antagonist
  • Anti-cancer activity
  • Click chemistry reagent
  • Contains an Alkyne group
  • Can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups

Catalog No. 50-004-38547 Supplier Medchemexpress LLC Supplier No. HY1127101MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

ORIC-101 is a highly potent and selective glucocorticoid receptor antagonist, with an EC50 of 5.6 nM. It has anti-cancer activity. Additionally, ORIC-101 is a click chemistry reagent, which means it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

  • Highly potent and selective glucocorticoid receptor antagonist
  • Anti-cancer activity
  • Click chemistry reagent
  • Contains an Alkyne group
  • Can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.